Follow the people · Insider
Ryan Cohlhepp
Ryan Cohlhepp files insider transactions with the SEC as a president and coo of Bicara Therapeutics (BCAX). We hold 10 disclosed purchases and sales filed since 8 October 2025, 3 of them in the last 90 days.
- Files forBCAX
- Disclosed buys and sells10 in all, 3 in the last 90 days
- Last disclosure12 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 6 October 2025 — 10 August 2026President and COO · Bicara Therapeutics (BCAX)69 Form 4 lines · source: SEC Form 4
Everything they disclosed
69 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 18,750 shares of Bicara TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- ▼ sold on the open market 18,750 shares of Bicara TherapeuticsSEC Form 412 August 2026Common Stock · traded 10 August 2026 · filed 12 August 2026
- exercised options over 18,750 shares of Bicara Therapeutics (a derivative holding)SEC Form 412 August 2026Stock Option (Right to Buy) · traded 10 August 2026 · filed 12 August 2026
- exercised options over 18,750 shares of Bicara TherapeuticsSEC Form 410 July 2026Common Stock · traded 8 July 2026 · filed 10 July 2026
- ▼ sold on the open market 22,833 shares of Bicara TherapeuticsSEC Form 410 July 2026Common Stock · traded 8 July 2026 · filed 10 July 2026
- ▼ sold on the open market 4,306 shares of Bicara TherapeuticsSEC Form 410 July 2026Common Stock · traded 8 July 2026 · filed 10 July 2026
- ▼ sold on the open market 1,075 shares of Bicara TherapeuticsSEC Form 410 July 2026Common Stock · traded 8 July 2026 · filed 10 July 2026
- ▼ sold on the open market 536 shares of Bicara TherapeuticsSEC Form 410 July 2026Common Stock · traded 9 July 2026 · filed 10 July 2026
- exercised options over 18,750 shares of Bicara Therapeutics (a derivative holding)SEC Form 410 July 2026Stock Option (Right to Buy) · traded 8 July 2026 · filed 10 July 2026
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 418 May 2026Common Stock · traded 15 May 2026 · filed 18 May 2026
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 418 May 2026Stock Option (Right to Buy) · traded 15 May 2026 · filed 18 May 2026
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 417 April 2026Common Stock · traded 15 April 2026 · filed 17 April 2026
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 417 April 2026Stock Option (Right to Buy) · traded 15 April 2026 · filed 17 April 2026
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 417 March 2026Stock Option (Right to Buy) · traded 16 March 2026 · filed 17 March 2026
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 417 March 2026Stock Option (Right to Buy) · traded 16 March 2026 · filed 17 March 2026
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 417 March 2026Common Stock · traded 16 March 2026 · filed 17 March 2026
- exercised options over 12,892 shares of Bicara TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 12,892 shares of Bicara TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 12,892 shares of Bicara Therapeutics (a derivative holding)SEC Form 45 March 2026Stock Option (Right to Buy) · traded 3 March 2026 · filed 5 March 2026
- exercised options over 12,892 shares of Bicara Therapeutics (a derivative holding)SEC Form 45 March 2026Stock Option (Right to Buy) · traded 3 March 2026 · filed 5 March 2026
- exercised options over 12,892 shares of Bicara TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 12,892 shares of Bicara TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 45 March 2026Common Stock · traded 3 March 2026 · filed 5 March 2026
- exercised options over 3,108 shares of Bicara TherapeuticsSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- ▼ sold on the open market 3,108 shares of Bicara TherapeuticsSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- ▼ sold on the open market 523 shares of Bicara TherapeuticsSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- exercised options over 3,108 shares of Bicara Therapeutics (a derivative holding)SEC Form 427 February 2026Stock Option (Right to Buy) · traded 25 February 2026 · filed 27 February 2026
- exercised options over 3,108 shares of Bicara Therapeutics (a derivative holding)SEC Form 427 February 2026Stock Option (Right to Buy) · traded 25 February 2026 · filed 27 February 2026
- exercised options over 3,108 shares of Bicara TherapeuticsSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- ▼ sold on the open market 3,108 shares of Bicara TherapeuticsSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- ▼ sold on the open market 523 shares of Bicara TherapeuticsSEC Form 427 February 2026Common Stock · traded 25 February 2026 · filed 27 February 2026
- was granted 300,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (Right to Buy) · traded 2 February 2026 · filed 4 February 2026
- was granted 300,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 44 February 2026Stock Option (Right to Buy) · traded 2 February 2026 · filed 4 February 2026
- ▼ sold on the open market 3,828 shares of Bicara TherapeuticsSEC Form 426 January 2026Common Stock · traded 22 January 2026 · filed 26 January 2026
- ▼ sold on the open market 3,828 shares of Bicara TherapeuticsSEC Form 426 January 2026Common Stock · traded 22 January 2026 · filed 26 January 2026
- ▼ sold on the open market 149 shares of Bicara TherapeuticsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- ▼ sold on the open market 149 shares of Bicara TherapeuticsSEC Form 420 January 2026Common Stock · traded 15 January 2026 · filed 20 January 2026
- exercised options over 25,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 429 December 2025Stock Option (Right to Buy) · traded 26 December 2025 · filed 29 December 2025
- exercised options over 25,000 shares of Bicara TherapeuticsSEC Form 429 December 2025Common Stock · traded 26 December 2025 · filed 29 December 2025
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 416 December 2025Stock Option (Right to Buy) · traded 15 December 2025 · filed 16 December 2025
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 416 December 2025Common Stock · traded 15 December 2025 · filed 16 December 2025
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 416 December 2025Common Stock · traded 15 December 2025 · filed 16 December 2025
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 416 December 2025Common Stock · traded 15 December 2025 · filed 16 December 2025
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 425 November 2025Stock Option (Right to Buy) · traded 21 November 2025 · filed 25 November 2025
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 425 November 2025Common Stock · traded 21 November 2025 · filed 25 November 2025
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 425 November 2025Common Stock · traded 21 November 2025 · filed 25 November 2025
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 425 November 2025Common Stock · traded 21 November 2025 · filed 25 November 2025
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 416 October 2025Stock Option (Right to Buy) · traded 15 October 2025 · filed 16 October 2025
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 416 October 2025Common Stock · traded 15 October 2025 · filed 16 October 2025
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 416 October 2025Common Stock · traded 15 October 2025 · filed 16 October 2025
- ▼ sold on the open market 4,500 shares of Bicara TherapeuticsSEC Form 416 October 2025Common Stock · traded 15 October 2025 · filed 16 October 2025
- exercised options over 24,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 6 October 2025 · filed 8 October 2025
- exercised options over 8,000 shares of Bicara Therapeutics (a derivative holding)SEC Form 48 October 2025Stock Option (Right to Buy) · traded 7 October 2025 · filed 8 October 2025
- exercised options over 24,000 shares of Bicara TherapeuticsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- ▼ sold on the open market 24,000 shares of Bicara TherapeuticsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- ▼ sold on the open market 15,600 shares of Bicara TherapeuticsSEC Form 48 October 2025Common Stock · traded 6 October 2025 · filed 8 October 2025
- exercised options over 8,000 shares of Bicara TherapeuticsSEC Form 48 October 2025Common Stock · traded 7 October 2025 · filed 8 October 2025
- ▼ sold on the open market 8,000 shares of Bicara TherapeuticsSEC Form 48 October 2025Common Stock · traded 7 October 2025 · filed 8 October 2025
- ▼ sold on the open market 2,900 shares of Bicara TherapeuticsSEC Form 48 October 2025Common Stock · traded 7 October 2025 · filed 8 October 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.